Eugia Pharma Specialities Ltd

General

Total Cases16

Active Cases2

Patents--

CourtsD. New Jersey D. Delaware D. Massachusetts

TypeOperating Company

Elite Ratings

--

--

--

--

Ratings

Experience

Grade

Trend

DCT

L4

E

PTAB

L4

E

CAFC

L4

C

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered	Case	Description
11/21/24	American Regent Inc v. Eugia Pharma Specialities Ltd 2:24-CV-08956 ( D. NJ )	***Civil Case Terminated per Order at [21] . (sm) (Entered: 11/21/2024)
11/07/24	American Regent Inc v. Eugia Pharma Specialities Ltd 2:24-CV-08956 ( D. NJ )	NOTICE of Appearance by STUART D. SENDER on behalf of All Defendants (SENDER, STUART) (Entered: 11/07/2024)
10/23/24	American Regent Inc v. Eugia Pharma Specialities Ltd 2:24-CV-08956 ( D. NJ )	STIPULATION AND ORDER OF CONSOLIDATION that all parties, through their attorneys, respectfully request that this Court consolidate Civil Action Nos. 24-7791, 24-7794, 24-7796, 24-7799, 24-8956, 24-7802, 24-7803, 24-7804, 24-7805, 24-7807, 24-7810, 24-7811, 24-7812 and that all papers be filed and maintained in Civil Action No. 24-7791; all filings in the Consolidated Action shall use the following caption going forward: IN RE SELENIOUS ACID LITIGATION. Signed by Magistrate Judge Cathy L. Waldor on 10/22/2024. (sm) (Entered: 10/23/2024) STIPULATION AND ORDER OF CONSOLIDATION that all parties, through their attorneys, respectfully request that this Court consolidate Civil Action Nos. 24-7791, 24-7794, 24-7796, 24-7799, 24-8956, 24-7802, 24-7803, 24-7804, 24-7805, 24-7807, 24-7810, 24-7811, 24-7812 and that all papers be filed and maintained in Civil Action No. 24-7791; all filings in the Consolidated Action shall use the following caption going forward: IN RE SELENIOUS ACID LITIGATION. Signed by Magistrate Judge Cathy L. Waldor on 10/22/2024. (sm) (Entered: 10/23/2024)
10/21/24	American Regent Inc v. Eugia Pharma Specialities Ltd 2:24-CV-08956 ( D. NJ )	Letter from Charles H. Chevalier to The Honorable Cathy L. Waldor, U.S.M.J. (Attachments: # [1] Text of Proposed Order)(CHEVALIER, CHARLES) (Entered: 10/21/2024)
10/16/24	Theravance Biopharma R&D IP LLC v. Eugia Pharma Specialties Ltd 1:23-CV-00926 ( D. NJ )	LETTER ORDER Granting Plaintiffs' [285] joint request for an extension of the deadline to file the motions to seal and redactions; the Parties shall file an omnibus motion to seal and their redactions on 10/29/2024. Signed by Judge Karen M. Williams on 10/16/2024. (mag) (Entered: 10/16/2024)
10/16/24	Theravance Biopharma R&D IP LLC v. Eugia Pharma Specialties Ltd 1:23-CV-00926 ( D. NJ )	CONSOLIDATION ORDER: The 926 Action and the 8558 Action are consolidated for all purposes, including discovery, case management, and trial, subject to further Order of the Court; all filings in the Consolidated Actions shall use the 926 Action Caption; all filings going forward shall be made in the 926 Action; and the 8558 Action shall be administratively terminated by the Clerk's Office; the Consolidated Actions will follow the amended schedule of the 926 Action. Signed by Judge Karen M. Williams on 10/15/2024. (sms2) (Entered: 10/16/2024) CONSOLIDATION ORDER: The 926 Action and the 8558 Action are consolidated for all purposes, including discovery, case management, and trial, subject to further Order of the Court; all filings in the Consolidated Actions shall use the 926 Action Caption; all filings going forward shall be made in the 926 Action; and the 8558 Action shall be administratively terminated by the Clerk's Office; the Consolidated Actions will follow the amended schedule of the 926 Action. Signed by Judge Karen M. Williams on 10/15/2024. (sms2) (Entered: 10/16/2024)
10/16/24	Theravance Biopharma R&D IP LLC v. Eugia Pharma Specialities Ltd 1:24-CV-08558 ( D. NJ )	CONSOLIDATION ORDER: The 926 Action and the 8558 Action are consolidated for all purposes, including discovery, case management, and trial, subject to further Order of the Court; all filings in the Consolidated Actions shall use the 926 Action Caption; all filings going forward shall be made in the 926 Action; and the 8558 Action shall be administratively terminated by the Clerk's Office; the Consolidated Actions will follow the amended schedule of the 926 Action. Signed by Judge Karen M. Williams on 10/15/2024. (sms2) (Entered: 10/16/2024) CONSOLIDATION ORDER: The 926 Action and the 8558 Action are consolidated for all purposes, including discovery, case management, and trial, subject to further Order of the Court; all filings in the Consolidated Actions shall use the 926 Action Caption; all filings going forward shall be made in the 926 Action; and the 8558 Action shall be administratively terminated by the Clerk's Office; the Consolidated Actions will follow the amended schedule of the 926 Action. Signed by Judge Karen M. Williams on 10/15/2024. (sms2) (Entered: 10/16/2024)
10/16/24	Theravance Biopharma R&D IP LLC v. Eugia Pharma Specialities Ltd 1:24-CV-08558 ( D. NJ )	***Civil Case Terminated. (sms2) (Entered: 10/16/2024)
10/15/24	Theravance Biopharma R&D IP LLC v. Eugia Pharma Specialties Ltd 1:23-CV-00926 ( D. NJ )	Letter from Arnold B. Calmann, Esq. to the Honorable Ann Marie Donio, U.S.M.J. Requesting Leave and Extension of Time to File Omnibus Motion to Seal and Redactions re [259] Exhibit (to Document),, [261] Exhibit (to Document),,,, [271] Letter,, [281] Transcript,,, [270] Letter,, [265] Letter,, [260] Exhibit (to Document),, [276] Letter,,, [262] Exhibit (to Document),,. (CALMANN, ARNOLD) (Entered: 10/15/2024) Letter from Arnold B. Calmann, Esq. to the Honorable Ann Marie Donio, U.S.M.J. Requesting Leave and Extension of Time to File Omnibus Motion to Seal and Redactions re [259] Exhibit (to Document),, [261] Exhibit (to Document),,,, [271] Letter,, [281] Transcript,,, [270] Letter,, [265] Letter,, [260] Exhibit (to Document),, [276] Letter,,, [262] Exhibit (to Document),,. (CALMANN, ARNOLD) (Entered: 10/15/2024)
10/15/24	Theravance Biopharma R&D IP LLC v. Eugia Pharma Specialties Ltd 1:23-CV-00926 ( D. NJ )	AMENDED SCHEDULING ORDER: Amended Pleadings or motion to join new parties due by 8/26/2025. Pretrial Fact Discovery due by 10/9/2025. Signed by Magistrate Judge Ann Marie Donio on 10/15/2024. (db, ) Modified on 10/16/2024 (tf, ). (Entered: 10/15/2024)